Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)
CAPS Rating:
The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.
The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.
Recs
Started a synthetic short @ $35.28 by selling Aug 50 calls and buying Aug 50 puts.